Multiple classes of the oligodendrocyte lineage are highly vulnerable to excitotoxicity

NeuroReport

Volumn 9, Issue 12, 1998, Pages 2757-2762

  McDonald, John W ^b   Levine, Joel M ^a   Qu, Yun ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell culture; Excitatory amino acid receptors; Excitotoxicity; Gal C (galactocerebroside); Glutamate; Kainate; MBP (myelin basic protein); Myelination; NG2; O2 A progenitors; Oligodendrocytes

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR; KAINIC ACID RECEPTOR;

ANIMAL CELL; ARTICLE; CELL LINEAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; MOUSE; MYELINATION; NEUROTOXICITY; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; WHITE MATTER;

EID: 0032563633     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199808240-00014     Document Type: Article

References (25)

1. Bunge RP, Puckett WRM Becerra JL et al. Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. In: Seil FJ, ed. Advances in Neurology. New York: Raven Press, 1993: 75-89.
2. McDonald JW, Althomsons SP, Hyrc KL et al. Nature Med 4, 291-297 (1998).
3. Yoshioka A, Hardy M, Younkin DP et al. J Neurochem 64, 2442-2448 (1995).
4. Matute C, Sanchez-Gomez MV, Martinez-Millan L et al. Proc Natl Acad Sci USA 94, 8830-8835 (1997).
5. Raff MC. Science 243, 1450-1455 (1989).
6. Miller RH. Trends Neurosci 19, 92-96 (1996).
7. Levine JM and Nishiyama A. Perspect Devel Neurobiol 3, 245-259 (1996).
8. Gard AL and Pfeiffer SE. Neurology 5, 615-625 (1990).
9. Rivkin MJ, Flax J, Mozell R et al. Ann Neurol 38, 92-101 (1995).
10. Nishiyama A, Yu M, Drazlou JA and Tuohy VK. J Neurosci Res 48, 299-312 (1997).
11. Reynolds R and Hardy R. J Neurosci Res 47, 455-470 (1997).
12. Wolswijk G and Noble M. Development 105, 387-400 (1989).
13. McDonald JW, Goldberg MP, Gwag BJ et al. Ann Neurol 40, 750-758 (1996).
14. Koh JY, Goldberg MP, Hartley DM et al. J Neurosci 10, 693-705 (1990).
15. Coyle JT, Molliver ME and Kuhar MJ. J Comp Neurol 180, 301-324 (1978).
16. Dusart I, Marty S and Peschanski M. Neuroscience 51, 137-148 (1992).
17. Raine CS. J Neuroimmunol 77, 135-152 (1997).
18. McDonald JW, Trescher WH and Johnston MV. Brain Res 583, 54-70 (1992).
19. Wood PM and Mora J. Adv Neurol 59, 113-123 (1993).
20. Steinhauser C and Gallo V. Trends Neurosci 19, 339-345 (1996).
21. Sheardown MJ, Suzdak PD and Nordholm L. Eur J Pharmacol 236, 347-353 (1993).
22. Wrathall JR, Choiniere D and Teng YD. J Neurosci 14, 6598-6607 (1994).
23. Bansal R, Warrington AE, Gard AL et al. J Neurosci Res 24, 548-557 (1989).
24. Sommer I and Schachner M. Dev Biol 83, 311-327 (1981).
25. Mirsky R, Winter J, Abney ER et al. J Cell Biol 84, 483-494 (1980).